Treatment regimens consisting of CTLA-4 Ig/anti-CD154 or agonistic anti-CD28/rapamycin have both been shown to prevent GVHD in fully allogeneic murine model systems. Using a transgenic approach to track the fate of host-reactive T cells in a minor antigen disparity model of GVHD, we found that while treatment with CTLA-4 Ig/anti-CD154 retained efficacy, the costimulation agonist anti-CD28 combined with rapamycin failed to prevent GVHD. Analysis of the host-reactive CD4(+) and CD8(+) T-cell responses revealed that in contrast to CTLA-4Ig/anti-CD154-treated recipients, host-reactive T cells in recipients treated with agonistic anti-CD28/rapamycin displayed enhanced and accelerated T-cell proliferation and failed to undergo activation-induced cell death. An increase in systemic levels of inflammatory cytokines was observed in the anti-CD28/rapamycin-treated recipients of the minor but not major antigen disparity bone marrow transplants. Our results demonstrate the intricacies of costimulatory receptor signaling pathways, and reveal how agonism of the CD28 pathway can have opposing outcomes depending on the degree of antigenic disparity.
Antigenic disparity impacts outcome of agonism but not blockade of costimulatory pathways in experimental transplant models. Publishing Authors By Initials
Antigenic disparity impacts outcome of agonism but not blockade of costimulatory pathways in experimental transplant models. Journal Published:
PUBLICATION TYPE: Research Support, N.I.H., Extr
Journal: American journal of transplantation : official jou
VOLUME: 7
Page Numbers: 1471-81
Journal Abbreviation: Am. J. Transplant.
ISSN: 1600-6135
DAY: 3
MONTH: Jun
YEAR: 2007
Antigenic disparity impacts outcome of agonism but not blockade of costimulatory pathways in experimental transplant models. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 100968638
Antigenic disparity impacts outcome of agonism but not blockade of costimulatory pathways in experimental transplant models. Keywords Mesh Terms:
KEYWORDS: Transplantation, Homologous
MESH TERMS: immunology
Chemical & Substance for Abstract: Antigenic disparity impacts outcome of agonism but not blockade of costimulatory pathways in experimental transplant models. Information
Substance Name: Sirolimus
Registry Number: 53123-88-9
Grant and Affiliation Information for Antigenic disparity impacts outcome of agonism but not blockade of costimulatory pathways in experimental transplant models.
AFFILIATION: Department of Surgery, Emory Transplant Center, Emory University, Atlanta, GA, USA.
Country: Denmark
AGENCY: United States NIAID
GRANT: AI040519
ACRONYM: AI
MEDLINETA: Am J Transplant
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Antigenic disparity impacts outcome of agonism but not blockade of costimulatory pathways in experimental transplant models Related Publications